Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib + SBRT for Advanced NSCLC
NCT00547105Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2007
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by UT Southwestern Medical Center. Started Jun 2007; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00547105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547105.